期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 890, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2020.173617
关键词
Emodin; Cardiovascular disease; Atherosclerosis; Therapeutic target
资金
- science and technology project of Huadu District of Guangzhou [18-HDWS-005]
Emodin is a pharmacologically bioactive constituent isolated from the traditional Chinese medicinal herb Radix rhizoma Rhei, with antioxidant, anti-inflammatory, anti-proliferative, anti-apoptotic, and lipid-modulating effects. Experimental studies have shown that emodin can attenuate and stabilize atherosclerotic plaques, highlighting its therapeutic potential in patients with cardiovascular disease.
Atherosclerotic plaque formation, destabilization and eventual rupture leads to the acute cardiovascular events including myocardial infarction and stroke. Emodin (PubChem CID#3220), (1,3,8-trihydroxy-6-methylanthracene-9,10-dione) is a pharmacologically bioactive constituent isolated from the traditional Chinese medicinal herb Radix rhizoma Rhei. This molecule has anti-oxidant, anti-inflammatory, anti-proliferative, anti-apoptotic and lipid-modulating effects. Experimental studies have demonstrated that emodin attenuates and stabilizes atherosclerotic plaques. In this mini-review, we provide a summary of the pharmacological actions of emodin in regulating vascular function and atherosclerosis, highlighting the therapeutic potential of this phytochemical in patients with cardiovascular disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据